# RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

Study · id `cardio:ct-nct05883631` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05883631](<https://clinicaltrials.gov/study/NCT05883631>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05883631

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 400 participants.

## Technical summary

Registry record NCT05883631. Non-randomized; no masking; primary purpose treatment. Start 2023-10-23 (actual); primary completion 2026-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT05883631, source copy `cardio:ctgov-nct05883631-2025-04-13`, retrieved 2026-10-26)
- Started: 2023-10-23 (actual) (ClinicalTrials.gov record NCT05883631, source copy `cardio:ctgov-nct05883631-2025-04-13`, retrieved 2026-10-26)
- Primary completion: 2026-01 (anticipated) (ClinicalTrials.gov record NCT05883631, source copy `cardio:ctgov-nct05883631-2025-04-13`, retrieved 2026-10-26)
- Completion: 2026-01 (anticipated) (ClinicalTrials.gov record NCT05883631, source copy `cardio:ctgov-nct05883631-2025-04-13`, retrieved 2026-10-26)
- Countries: United States; Belgium; Czechia; Netherlands (ClinicalTrials.gov record NCT05883631, source copy `cardio:ctgov-nct05883631-2025-04-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05883631-2025-04-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
- Acronym: RESOLVE-AF
- Condition: Atrial Fibrillation
- Condition: Atrial Fibrillation, Persistent
- Condition: Atrial Fibrillation Paroxysmal
- Condition: Arrhythmia
- Condition: Arrhythmias, Cardiac
- Condition: Atrial Flutter
- Condition: Atrial Fibrillation, Paroxysmal or Persistent
- Condition: Atrial Arrhythmia
- Condition: Atrial Tachycardia
- Intervention (Device): Electrographic Flow (EGF) mapping and ablation of EGF-identified sources of Atrial Fibrillation
- Intervention (Device): Electrographic Flow (EGF) mapping (no ablation)
- Lead sponsor: Cortex
- Lead sponsor class: INDUSTRY
- Collaborator: Ablacon, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)

## Provenance

Content hash: c6380add148132a66ed347906af846f831b9c18bfd32f4f742c800d8a602c011
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
